Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Puma Biotechnology (PBYI) EPS (Basic): 2017-2024

Historic EPS (Basic) for Puma Biotechnology (PBYI) over the last 8 years, with Dec 2024 value amounting to $0.62.

  • Puma Biotechnology's EPS (Basic) fell 56.10% to $0.18 in Q3 2025 from the same period last year, while for Sep 2025 it was $0.75, marking a year-over-year increase of 56.25%. This contributed to the annual value of $0.62 for FY2024, which is 34.78% up from last year.
  • According to the latest figures from FY2024, Puma Biotechnology's EPS (Basic) is $0.62, which was up 34.78% from $0.46 recorded in FY2023.
  • In the past 5 years, Puma Biotechnology's EPS (Basic) registered a high of $0.62 during FY2024, and its lowest value of -$1.52 during FY2020.
  • Over the past 3 years, Puma Biotechnology's median EPS (Basic) value was $0.46 (recorded in 2023), while the average stood at $0.36.
  • Data for Puma Biotechnology's EPS (Basic) shows a peak YoY spiked of 1,049,623.10% (in 2023) over the last 5 years.
  • Puma Biotechnology's EPS (Basic) (Yearly) stood at -$1.52 in 2020, then soared by 52.63% to -$0.72 in 2021, then surged by 100.01% to $0.00 in 2022, then soared by 1,049,623.10% to $0.46 in 2023, then surged by 34.78% to $0.62 in 2024.